Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib

Prognostic classifications for patients treated with sorafenib for hepatocellular carcinoma (HCC) facilitate stratification in trials and inform clinical decision making. Recently, 3 different prognostic models (hepatoma arterial-embolization prognosis [HAP] score, sorafenib advanced HCC prognosis [...

Descripción completa

Detalles Bibliográficos
Autores principales: Sansone, Vito, Tovoli, Francesco, Casadei-Gardini, Andrea, Di Costanzo, Giovan Giuseppe, Magini, Giulia, Sacco, Rodolfo, Pressiani, Tiziana, Trevisani, Franco, Rimini, Margherita, Tortora, Raffaella, Nardi, Elena, Ielasi, Luca, Piscaglia, Fabio, Granito, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808555/
https://www.ncbi.nlm.nih.gov/pubmed/33443944
http://dx.doi.org/10.14309/ctg.0000000000000286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808555/
https://www.ncbi.nlm.nih.gov/pubmed/33443944
http://dx.doi.org/10.14309/ctg.0000000000000286

Ejemplares similares